T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Microsoft
MSFT
|
+$2.25B |
| 2 |
Sea Limited
SE
|
+$1.98B |
| 3 |
Morgan Stanley
MS
|
+$1.41B |
| 4 |
Incyte
INCY
|
+$1.13B |
| 5 |
Ross Stores
ROST
|
+$911M |
Top Sells
| 1 |
Boeing
BA
|
+$2.44B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.68B |
| 3 |
Visa
V
|
+$1.23B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.22B |
| 5 |
JPMorgan Chase
JPM
|
+$1.12B |
Sector Composition
| 1 | Technology | 25.02% |
| 2 | Healthcare | 17.61% |
| 3 | Consumer Discretionary | 14.48% |
| 4 | Financials | 11.79% |
| 5 | Communication Services | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Gentex
GNTX
$6.25B
| $4.07M | ﹤0.01% |
157,931
-16,658
| -10% | -$429K |
|
1402
United Therapeutics
UTHR
$18.3B
| $4.05M | ﹤0.01% |
33,477
-221,354
| -87% | -$26.8M |
|
1403
Ranger Energy Services
RNGR
$298M
| $4.02M | ﹤0.01% |
1,363,569
| – | – |
|
1404
Crown Holdings
CCK
$11.2B
| $3.95M | ﹤0.01% |
60,635
-5,943
| -9% | -$387K |
|
1405
Dell
DELL
$84.1B
| $3.93M | ﹤0.01% |
141,081
-31,369
| -18% | -$874K |
|
1406
Lyft
LYFT
$7.73B
| $3.92M | ﹤0.01% |
118,652
-208,242
| -64% | -$6.87M |
|
1407
Royal Bank of Canada
RY
$203B
| $3.91M | ﹤0.01% |
57,862
-54
| -0.1% | -$3.65K |
|
1408
Ingredion
INGR
$8.09B
| $3.9M | ﹤0.01% |
47,031
+297
| +0.6% | +$24.7K |
|
1409
Commercial Metals
CMC
$6.47B
| $3.9M | ﹤0.01% |
190,977
-12,029
| -6% | -$245K |
|
|
TCF
1410
DELISTED
TCF Financial Corporation Common Stock
TCF
| $3.87M | ﹤0.01% |
131,524
+10,467
| +9% | +$308K |
|
|
AYX
1411
DELISTED
Alteryx, Inc.
AYX
| $3.84M | ﹤0.01% |
23,371
-2,118
| -8% | -$348K |
|
1412
Axon Enterprise
AXON
$59.4B
| $3.79M | ﹤0.01% |
38,664
-7,507
| -16% | -$737K |
|
1413
TETRA Technologies
TTI
$630M
| $3.66M | ﹤0.01% |
6,853,767
-3,587,540
| -34% | -$1.92M |
|
1414
Hillenbrand
HI
$1.73B
| $3.66M | ﹤0.01% |
135,296
-12,850
| -9% | -$348K |
|
1415
Cyclerion Therapeutics
CYCN
$7.88M
| $3.66M | ﹤0.01% |
30,976
-2,958
| -9% | -$350K |
|
1416
Skechers
SKX
$9.49B
| $3.66M | ﹤0.01% |
116,469
+7,793
| +7% | +$245K |
|
1417
Akero Therapeutics
AKRO
$3.48B
| $3.65M | ﹤0.01% |
146,532
-92,946
| -39% | -$2.32M |
|
1418
Universal Display
OLED
$6.49B
| $3.64M | ﹤0.01% |
24,310
+742
| +3% | +$111K |
|
1419
Grupo Aval
AVAL
$4.02B
| $3.62M | ﹤0.01% |
829,200
-11,036,701
| -93% | -$48.1M |
|
|
NUAN
1420
DELISTED
Nuance Communications, Inc.
NUAN
| $3.6M | ﹤0.01% |
142,194
-6,224
| -4% | -$157K |
|
1421
Quince Therapeutics
QNCX
$85.9M
| $3.57M | ﹤0.01% |
77,166
-6,195
| -7% | -$287K |
|
1422
Bloom Energy
BE
$15.7B
| $3.55M | ﹤0.01% |
326,687
-50,388
| -13% | -$548K |
|
1423
SiriusXM
SIRI
$7.84B
| $3.53M | ﹤0.01% |
60,180
-18,043
| -23% | -$1.06M |
|
1424
Star Group
SGU
$387M
| $3.52M | ﹤0.01% |
401,325
| – | – |
|
1425
Lear
LEA
$5.62B
| $3.51M | ﹤0.01% |
32,182
-1,121
| -3% | -$122K |
|